Collegium Pharmaceutical, Inc. drugs
3 results
Nucynta (tapentadol hydrochloride)
(tapentadol hydrochloride)Collegium Pharmaceutical, Inc.
Usage: NUCYNTA ER (tapentadol) is indicated for managing severe and persistent pain in adults requiring long-term opioid treatment, where other options are inadequate. It is also approved for severe neuropathic pain related to diabetic peripheral neuropathy in adults. Not intended for as-needed analgesic use.
Nucynta (tapentadol hydrochloride)
(tapentadol hydrochloride)Collegium Pharmaceutical, Inc.
Usage: NUCYNTA (tapentadol) tablets are indicated for managing acute pain in adults and pediatric patients (aged 6 years and older, weight ≥40kg) when alternative treatments are insufficient. Due to addiction risks, it should be reserved for patients who cannot tolerate or achieve adequate relief with other analgesics.
Xtampza (oxycodone)
(OXYCODONE)Collegium Pharmaceutical, Inc.
Usage: XTAMPZA ER is indicated for managing severe, persistent pain requiring long-term opioid treatment when alternatives are inadequate. It's not recommended for as-needed use. Due to addiction risks, it should only be prescribed when other options are ineffective or intolerable.